SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-22-000678
Filing Date
2022-04-21
Accepted
2022-04-21 16:04:53
Documents
13
Period of Report
2022-04-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e621582_8k-plx.htm   iXBRL 8-K 30347
2 e621582_ex3-1.htm EX-3.1 180574
  Complete submission text file 0001193805-22-000678.txt   427772

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plxp-20220420.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20220420_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION plxp-20220420_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT e621582_8k-plx_htm.xml XML 3692
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 22841427
SIC: 2834 Pharmaceutical Preparations